3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer-Reference-Cited by-同舟云学术

3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer

Published:2004-04 Issue:1 Volume:71 Page:35-41
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Martin Thomas,Röddiger Sandra,Kurek Ralf,Dannenberg Thomas,Eckart Oliver,Kolotas Christos,Heyd Reinhard,Rogge Bernd,Baltas Dimos,Tunn Ulf,Zamboglou Nikolaos

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference36 articles.

1. Consensus statement: guidelines for PSA following radiation therapy;Int J Radiat Oncol Biol Phys,1997

2. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

3. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland;Borghede;Radiother Oncol,1997

4. Treatment of prostate cancer using a proactive decision-making process;Brabbins;Radiother Oncol,1998

5. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue;Brenner;Int J Radiat Oncol Biol Phys,2002

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐dose‐rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome;Cancer Reports;2021-06-23

2. Long-Term Outcomes of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-Stage Nasopharyngeal Carcinoma;Frontiers in Oncology;2019-04-26

3. High Dose Rate Brachytherapy as Monotherapy for Localised Prostate Cancer: Review of the Current Status;Clinical Oncology;2017-07

4. In vivo dosimetry with alanine/electron spin resonance dosimetry to evaluate the urethra dose during high-dose-rate brachytherapy;Brachytherapy;2017-07

5. The evolution of brachytherapy for prostate cancer;Nature Reviews Urology;2017-06-30